17-76007196-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001988.4(EVPL):​c.6009C>A​(p.Asp2003Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000455 in 1,539,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000043 ( 0 hom. )

Consequence

EVPL
NM_001988.4 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.82
Variant links:
Genes affected
EVPL (HGNC:3503): (envoplakin) This gene encodes a member of the plakin family of proteins that forms a component of desmosomes and the epidermal cornified envelope. This gene is located in the tylosis oesophageal cancer locus on chromosome 17q25, and its deletion is associated with both familial and sporadic forms of oesophageal squamous cell carcinoma. Patients suffering from the autoimmune mucocutaneous disorder, paraneoplastic pemphigus, develop antibodies against the encoded protein. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4025354).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EVPLNM_001988.4 linkc.6009C>A p.Asp2003Glu missense_variant 22/22 ENST00000301607.8 NP_001979.2 Q92817
EVPLNM_001320747.2 linkc.6075C>A p.Asp2025Glu missense_variant 22/22 NP_001307676.1 Q92817K7EKI0B7ZLH8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EVPLENST00000301607.8 linkc.6009C>A p.Asp2003Glu missense_variant 22/221 NM_001988.4 ENSP00000301607.3 Q92817
EVPLENST00000586740.1 linkc.6075C>A p.Asp2025Glu missense_variant 22/221 ENSP00000465630.1 K7EKI0
EVPLENST00000589231.1 linkc.246C>A p.Asp82Glu missense_variant 1/23 ENSP00000467717.1 K7EQ87
EVPLENST00000587569.5 linkn.6478C>A non_coding_transcript_exon_variant 20/202

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152264
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000101
AC:
2
AN:
198882
Hom.:
0
AF XY:
0.0000188
AC XY:
2
AN XY:
106334
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000120
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000433
AC:
6
AN:
1387022
Hom.:
0
Cov.:
30
AF XY:
0.00000733
AC XY:
5
AN XY:
682202
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000154
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152264
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000192
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000435
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000826
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 05, 2024The c.6009C>A (p.D2003E) alteration is located in exon 22 (coding exon 22) of the EVPL gene. This alteration results from a C to A substitution at nucleotide position 6009, causing the aspartic acid (D) at amino acid position 2003 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Benign
-0.041
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
0.14
Eigen_PC
Benign
0.050
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.75
T;T;T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.40
T;T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
1.3
.;L;.
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-2.4
.;N;.
REVEL
Uncertain
0.43
Sift
Pathogenic
0.0
.;D;.
Sift4G
Benign
0.081
T;D;D
Polyphen
1.0
.;D;.
Vest4
0.78, 0.73
MutPred
0.33
.;Gain of ubiquitination at K2002 (P = 0.0913);.;
MVP
0.74
MPC
0.72
ClinPred
0.86
D
GERP RS
1.3
Varity_R
0.78
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767501449; hg19: chr17-74003277; API